Publications To Date

    nCOUNTER PUBLICATIONS

    Filter Publications

    PAGE 7 OF 146 | DISPLAYING 91 - 105 OF 2181 RESULTS

    De. Jager P.L. et. al., A multi-omic atlas of the human frontal cortex for aging and Alzheimer’s disease research, https://doi.org/10.1038/sdata.2018.142, Scientific Data, Aug 07, 2018

    Dahl M. et. al., Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies, https://doi.org/10.1038/s41374-018-0108-6, Lab. Invest., Aug 07, 2018

    Ehrlich A.T. et. al., Expression map of 78 brain-expressed mouse orphan GPCRs provides a translational resource for neuropsychiatric research, https://doi.org/10.1038/s42003-018-0106-7, Communications Biology, Aug 06, 2018

    Chan J.P. et. al., The lysolipid transporter Mfsd2a regulates lipogenesis in the developing brain, 10.1371/journal.pbio.2006443, PLoS bIOL., Aug 03, 2018

    Silva J.P. et. al., Analysis of diet-induced differential methylation, expression, and interactions of lncRNA and protein-coding genes in mouse liver, https://doi.org/10.1038/s41598-018-29993-4, Sci. Reports, Aug 01, 2018

    Kim S-S. et. al., Combination with SGT-53 overcomes tumor resistance to a checkpoint inhibitor, 10.1080/2162402X.2018.1484982, Oncoimmunology, Aug 01, 2018

    Li Y. et. al., A human immune system mouse model with robust lymph node development, https://doi.org/10.1038/s41592-018-0071-6, Nature Med., Jul 31, 2018

    Polumuri S.K. et. al., Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities, https://doi.org/10.1038/s41598-018-29850-4, Sci. Reports, Jul 31, 2018

    Alidousty C. et. al., Genetic instability and recurrent MYC amplification in ALK‐translocated NSCLC: a central role of TP53 mutations, 10.1002/path.5110, J. Pathol., Jul 31, 2018

    Kim Y-S. et. al., Fibroblast growth factor receptor 3 (FGFR3) aberrations in muscle-invasive urothelial carcinoma, 10.1186/s12894-018-0380-1, BMC. Urol., Jul 31, 2018

    de Vos S. et. al., Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study, 10.1093/annonc/mdy256, Ann. Oncol., Jul 28, 2018

    Liu H. et. al., Functional convergence of gliP and aspf1 in Aspergillus fumigatus pathogenicity, 10.1080/21505594.2018.1482182, Virulence, Jul 27, 2018

    Jensen M-B. et. al., The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer, 10.1186/s13058-018-1012-0, Breast Can. Res., Jul 27, 2018

    Oliviera J.J. et. al., The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus, 10.1186/s13075-018-1649-1, Arthritis Res. Ther., Jul 27, 2018

    Ghaffari A. et. al., STING agonist therapy in combination with PD-1 immune checkpoint blockade enhances response to carboplatin chemotherapy in high-grade serous ovarian cancer, https://doi.org/10.1038/s41416-018-0188-5, Br. J. Cancer, Jul 26, 2018